Purple Biotech Rings the Nasdaq Stock Market Opening Bell
Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, rang ...
Read More
Read More
Hadassah & NeuroGenesis Achieve Groundbreaking Results in Multiple Sclerosis Study
Clinical trials for NeuroGenesis’ new stem cell treatment have stopped the progression of multiple sclerosis (MS), and left some patients ...
Read More
Read More
Wizecare to provide Remote Physical Rehabilitation to Meuhedet, Israel’s 3rd Largest HMO
WizeCare signed a five year nation wide contract to provide remote physical rehabilitation services to Meuhedet. The deal was signed ...
Read More
Read More
VOTIS to Develop Device for Screening Peripheral Arterial Foot Disease for India
VOTIS Subdermal Imaging Technology (VOTIS) in Israel and ii Ventures Private Limited (iiV) in India will develop a system to ...
Read More
Read More
Yarok Microbio Fast Testing to stop Food Recalls and Plant Pathogens
Jerusalem based Yarok MicroBio combines biochemicals with machine vision and digital image analysis to detect dangerous microbes, such as E.coli, ...
Read More
Read More
Israeli Anti-Viral Mask Maker Sonovia Expands Global Marketing Campaign as It Completes IPO
Sonovia Ltd, which produces and markets masks made from the their anti-bacterial & antiviral fabrics, sees itself on the forefront ...
Read More
Read More
OrCam Plans $3 billion Valuation in 2021 IPO
OrCam Technologies Ltd, founded and run by Prof Amnon Shashua and Ziv Aviram, is set to go public in New ...
Read More
Read More
Nanox’s Next Generation Radiology Rocks the RSNA 2020!
NANO-X IMAGING LTD (NASDAQ: NNOX) successfully demonstrated its Nanox.ARC next-generation x-ray prototype at the 2020 annual conference of the Radiological ...
Read More
Read More
Alpha TAU Medical raises $26 million funding as it moves to Jerusalem
Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, finished in June the closing of a Series ...
Read More
Read More
FDA Accepts Atox Bio’s Reltecimod to Treat Suspected Organ Dysfunction/Failure re “Flesh-Eating Disease”
The U.S. Food and Drug Administration (FDA) has accepted to Atox Bio’s filing of the New Drug Application (NDA) for ...
Read More
Read More
Ascento Medical Gives New Hope for Alzheimer’s and Dementia Patients
Ascento Medical is a company in the field of Dementia and Alzheimer’s treatment & prevention, using Artificial Intelligence and Machine ...
Read More
Read More
KAHR Announces First Patient Dosed in DSP107 Treatment of Solid Tumors Phase 1/2 Clinical Trial
Jerusalem based KAHR MEDICAL, a cancer immunotherapy company developing novel multifunctional immuno-recruitment proteins, started treating the first patient in its ...
Read More
Read More
Raziel Closes Market License Agreement for RZL 012 with Fosun Pharma
Raziel Therapeutics, a Pharmaceutical company, is developing a novel synthetic small molecule (NCE) for aesthetics and fat disorders next-generation novel ...
Read More
Read More
Oramed to Start Pivotal Phase 3 Oral Insulin Studies
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company is about to start their Phase 3 Studies ...
Read More
Read More
Omnix Medical Raises $8.5 million for its Novel Drug Targeting AMR Bacteria
Omnix Medical just raised an additional $8.5 million to bring its promising AMR (antimicrobial resistance) drug, OMN6, for the treatment ...
Read More
Read More
Promising Results in Immunity Pharma’s Interim Phase 1/2a IPL344 in ALS Study
The new treatment being developed by Immunity Pharma may give ALS (Lou Gehrig’s Disease) patients hope. ALS is an “orphan ...
Read More
Read More
Mapi Pharma In Talks To Produce Covid-19 Vaccine in Jerusalem
Israeli drug development company Mapi Pharma announced today that it will dedicate capacity at its manufacturing facility in Jerusalem's Har ...
Read More
Read More
FIMI Buys Rafa Laboratories for NIS 700m Valuation
FIMI Opportunity Funds has acquired from the Sackler family a 90% stake in Israeli pharmaceutical company Rafa Laboratories Ltd. at a ...
Read More
Read More
Cell Therapy QC Company, Accellix, Raised $9.5 Million in Series D Round
Jerusalem based, Accellix, the Cell Therapy QC company, had a Series D financing round of $9.5 million led by bioMérieux, ...
Read More
Read More
Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine
The Hadassah Medical Organization is slated to begin a clinical trial with an Israeli-made COVID-19 vaccine in October. One hundred ...
Read More
Read More
MYOR Begins US Commercialization of its Breakthrough Platform to Prevent Allergic Conditions
MYOR's NURTURE Precision Infant Care enables prevention of food allergies and atopic dermatitis via early prediction in newborns. NURTURE, a ...
Read More
Read More
Enlivex’s Experimental Allocetra Drug Saves Five Covid Patients at Hadassah Hospital
Hadassah Hospital released five fully recuperated patients who were in critical condition with coronavirus, due to their treatment with the ...
Read More
Read More
Novellus Raises $57M!
Novellus, Ltd., a Jerusalem-based clinical-stage biotechnology company focused on precision oncology and cancer treatment, raised $ 57 million in a ...
Read More
Read More
BiondVax Pharmaceuticals Universal Flu Vaccine Pivotal Phase 3 Study Results by End October
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ’s pivotal Phase 3 trial in Europe was completed in June 2020 and the analysis ...
Read More
Read More
WizeCare Smart Physical Therapy Homecare Co to Raise $1M via Crowd Funding
You can participate in the WizeCare crowdfunding campaign https://pipelbiz.com/Campaign/52785. Concerns about health and safety in the face of the coronavirus ...
Read More
Read More
Visibly Impaired Read More Efficiently than the Sighted via OrCam’s Breakthrough!
Jerusalem-based OrCam Technologies announced the US release of a new, voice-activated, interactive Smart Reading feature providing users who are blind, ...
Read More
Read More
BrainsWay Receives FDA Clearance for Ending Smoking Addiction in Adults
BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, has received 510(k) ...
Read More
Read More
Concenter BioPharma Successfully Uses Crowdfunding to Finance Its Pill To End Diabetes!
Concenter BioPharma has raised $407 K (as of August 24 1.3 Million NIS) in just ten days using the PipelBiZ ...
Read More
Read More
Nanox raises $165.2m in Nasdaq IPO!
Congratulations to Ran Poliakine! The largest-ever IPO of an early stage Israeli medical technology company was completed at a company ...
Read More
Read More
Alternative Meat Company SavorEat Raises $4.75 M
SavorEat announced that it raised Funds from The Mor and Meitav Dash investment houses will invest $3 million, and $1.75 ...
Read More
Read More
Kamada’s COVID Antibody Drug Small Trial, a World 1st, gets Flying Start at Hadassah in Jerusalem
The world’s first clinical trial for a coronavirus drug made from antibodies got off to a promising start at the ...
Read More
Read More
Will Nanox be the Next Israeli Hit on Nasdaq?
NANO-X IMAGING LTD , an innovative medical imaging technology company, has secured over $110M in crossover equity investments from global ...
Read More
Read More
EDAS Instant Respiratory Diagnosis wins Israel Innovation Authority COVID-19 Grant
EDAS Healthcare is a patented decision support software, enabling immediate prediction of an infectious disease, upon the first patient encounter ...
Read More
Read More
Future Meat wins Calcalist’s FoodTech innovation startup contest
Future Meat Technologies Ltd. was crowned Wednesday as the winner of Calcalist’s startup contest, in partnership with Tnuva, aimed at ...
Read More
Read More
FDA OKs KAHR Medical IND Application for DSP107, anti-CD47 Candidate for Solid Tumors Treatment
KAHR Medical, a cancer immunotherapy company developing novel bi-functional fusion proteins, announced today that the U.S. Food and Drug Administration ...
Read More
Read More
Betalin’s Micro-Pancreas to ‘Cure’ Diabetes Ready for UK Trials
Jerusalem based Betalin Therapeutics will be submitting a request to Britain’s regulatory agency in August for human clinical trials in ...
Read More
Read More
NOBIO COVID-19 Personal Protection Coatings Awarded Israel Innovation Authority Grant
Nobio was recently awarded a $205,000 grant from the Israel Innovation Authority to rapidly develop personal protection and surface coatings ...
Read More
Read More
Yissum Spinouts Raise Record $79 million in H1 2020 Despite Coronavirus
(July 28, 2020– Jerusalem) Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020, ...
Read More
Read More
New Israeli Trial on Possible Pomegranate Oil Prevents Age Related Brain Decline
Jerusalem based Granalix is to be teaming up with the Rambam Medical Center’s Memory Clinic on a new clinical trial ...
Read More
Read More
Oramed Oral Insulin for Treatment of Diabetes Gets 3rd Phase Clinical Trials Greenlight
The Need Diabetes and its prevalence in modern society have been a major international health concern for some time. Health ...
Read More
Read More
Anchiano Appoints Stan Polovets as Chairman of the Board
Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”) recently announced that Mr. Stan Polovets has been elected chairman of its board of ...
Read More
Read More
Gamida Cell Adds David Fox to Board of Directors
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood ...
Read More
Read More
JLM Immuno-Oncology Company Nectin raises $6m from Amoon
Nectin Therapeutics is developing a number of antibodies that can enhance the treatments being offered to cancer patients. Jerusalem immuno-oncology ...
Read More
Read More
Atox Bio’s Reltecimod Effective in Phase 3 Clinical Trials against Flesh Eating Disease
Reltecimod is Atox Bio's lead product in development and is currently in late stage clinical trials for Necrotizing Soft Tissue ...
Read More
Read More
US FDA OKs Immunovative Therapies Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Elderly
Immunovative Therapies' universal vaccine is designed to protect elderly adults from all respiratory viral infections, including COVID-19, influenza and any ...
Read More
Read More
BiondVax’s M-001 Universal Influenza Vaccine Completes Successful NIH Phase 2 Clinical Trial
The NIAID of the NIH completed the Clinical Study Report (CSR) of a Phase 2 clinical trial of the BiondVax’s ...
Read More
Read More
Betalin Therapeutics Awarded funding from Fast Track to Innovation (FTI) of the Horizon 2020 program
The funding award to Betalin Therapeutics along with their partners from Dresden and Zurich was just announced. The demand for ...
Read More
Read More
Silkim Pharma’s New Drug Against Coronavirus Receives Response from FDA in Record Time!!
On April 22nd, Silkim Pharma filed a pre-Investigational New Drug (PIND) meeting request with the U.S. Food and Drug Administration ...
Read More
Read More
Gamida Cell Hits Goal in Phase 3 Blood Cancer Trial
Gamida Cell Ltd (Nasdaq: GMDA) is an advanced cell therapy company that uses umbilical cord blood, a rich source of ...
Read More
Read More
Nanox Signs with Hadassah Medical Org for Nanox.ARC Novel Early-Detection Protocols Dev
NANO-X IMAGING LTD, an innovative medical-imaging technology company, announces today a partnership agreement with the Hadassah Hospital in Jerusalem, to ...
Read More
Read More
Latest Jerusalem Startup Uses AI to Defeat Dementia and Alzheimer’s!
Based on over 4000 successfully treated patients carried out Prof. Eli Wertman and his team, Ascento Medical will be offering ...
Read More
Read More
Soapy Washes Your Hands Clean Of Corona!
Israeli startup, Soapy, provides an innovative solution for hand-hygiene maintenance and compliance. Their ECO Micro-Stations indicate to users when they ...
Read More
Read More
POMICELL Applies AI to Accelerate Novel Therapies for COVID19
Jerusalem-based POMICELL is using its artificial intelligence solution to create a Coronavirus (COVID19) computational model that aims to enhance discovery ...
Read More
Read More
OmnySense Prepares for the Next Pandemic
OmnySense Ltd., a leader in enabling remote medical-grade checkups, is proposing to national health authorities and stockpiles to use its ...
Read More
Read More
RenalSense Presents Unique Monitoring Solution for Isolated Coronavirus Patients
RenalSense’s sensor based, real-time urine output monitoring system, the Clarity RMS®, provides new value among patients in isolation. With the ...
Read More
Read More
BATM CEO: Salvation will come from Jerusalem and Zion!
A Coronavirus diagnostic test kit, designed to allow people to test a sputum sample at home, is to be able ...
Read More
Read More
Congratulations to Yissum Spin-out CollPlant for Raising $4.45M in the Capital!
CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced it has entered into definitive agreements for up to $4.45 ...
Read More
Read More
Hadassit’s Enlivex Therapeutics Closes $16.75M Registered Direct Offering
Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the closing of its previously announced registered direct offering ...
Read More
Read More
ATLASense Biomed Earns Henry Ford Health System’s Global Health Tech Challenge Top Prize
Congratulations to Dan Atlas and Tal OR for winning the 2020 Henry Ford Health System’s Global Health Tech Challenge ! ...
Read More
Read More
Nano-X Signs $174M Australian Distribution Agreement
Israel-based medical imaging startup Nano-X Imaging Ltd. has signed an exclusive distribution agreement with Prestons, Australia-based the Gateway Group. As ...
Read More
Read More
JLM Cancer Treatment Company Kahr Medical raises $18m
KAHR Medical Ltd., a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as Dual ...
Read More
Read More
DouxMatox among the top 50 Cos Worldwide in the SVG Ventures-THRIVE 2020 Food Tech Sector
DouxMatox was selected among the top 50 companies worldwide in the Foodtech and Agtech (agriculture tech) sectors in 2020, put ...
Read More
Read More
Future Meat listed on SVG Ventures THRIVE Top 50 AgTech & FoodTech Cos worldwide
Future Meat Technologies was listed among two separate lists highlighting the top 50 companies worldwide in the Foodtech and Agtech ...
Read More
Read More
Argaman Technologies Viral Deactivation Face Masks to Hong Kong to fight Coronavirus!
Jerusalem based Argaman Technologies, Ltd. presents its Viral Deactivation Face Masks which are headed to Hong Kong to fight the ...
Read More
Read More
RenalSense starts Delivery of its First Orders of Clarity RMS in Europe
RenalSense has started commercial sales of its Clarity RMS™ system in Europe with its distribution partner Fresenius Medical Care (Bad ...
Read More
Read More
Genetika+ Won Three International Awards in 2019!
Genetika + is a Jerusalem based biotech start-up developing cutting edge technology to determine which anti-depressant is best suited to ...
Read More
Read More
Good News from the NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax’s M-001 Universal Influenza Vaccine Candidate
Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax’s M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical ...
Read More
Read More
Successful BrainsWay Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as Smoking Cessation Aid
BrainsWay Ltd. achieved final positive results from its pivotal multicenter trial on the safety and efficacy of the Company’s H4 ...
Read More
Read More
Finally, a Pill that Could Fix the Cause of Type2 Diabetes
Zygosid-50, a drug under development in Israel, could be the first to treat type 2 diabetes by restoring the body’s ...
Read More
Read More
Augmedics Announces U.S. Launch of xvision, First Augmented Reality Surgery Guidance System
Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and ...
Read More
Read More
Novelstem Increases Newstem Ownership to 27.3%
Following achievement of an important milestone for Stem-Cell based cancer treatments resistance diagnostics, Jerusalem based NewStem received a further $ ...
Read More
Read More
Fat Melting Pharmaceutical Company Raziel Therapeutics Raises $22 Million
Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with the participation of ...
Read More
Read More
Concenter Biopharma Ltd. is developing a Promising Drug for Treating and Preventing Type 2 Diabetes (T2D)
Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically ...
Read More
Read More
SaliStick of Salignostics-the World’s First Saliva Rapid Pregnancy Test at Medica Expo, Germany
During the MEDICA exhibition in Düsseldorf, Germany, on November 18, Salignostics present for the first time the world's first saliva rapid pregnancy ...
Read More
Read More
Interview with Pepticom CEO Dr. Immanuel Lerner, and head of busdev Mayaan Maayan Elias Robicsek, Ph.D., MBA, BSc
PepDiscovery of Novel Peptide Drug Candidates by Artificial Intelligence Design. Interview conducted by Ben Woolf and Deborah Amsallem on 15th ...
Read More
Read More
Entera Bio recently entered into a $270 million license agreement with Amgen
Entera Bio's platform technology enables oral therapies based on molecules that would otherwise undergo gastric degradation and have limited or ...
Read More
Read More
Pepticom Raises $5 million in Series A Funding
Jerusalem based Pepticom, a leader in artificial intelligence peptide drug discovery, has secured $5 million in Series A funding from ...
Read More
Read More
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
Jerusalem-based Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Swiss Lonza (SWX: LONN), an integrated healthcare solutions provider, ...
Read More
Read More
Accellix signs Co-Development Agreement with Orgenesis
Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform ...
Read More
Read More
EU awards HIL Applied Medical with €2.5M in Grant Funding
The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – approved HIL’s Phase-II proposal, ...
Read More
Read More
Atox Bio gets BARDA Support for Continued Development of Reltecimod for Necrotizing Soft Tissue Infections
Atox Bio, a late-stage clinical company developing immunotherapies for critically ill patients, announced that the Biomedical Advanced Research and Development ...
Read More
Read More
KAHR Medical Announces Clinical Trial Collaboration with ROCHE in Advanced Lung Cancer Patients
KAHR Medical Ltd , a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as ...
Read More
Read More
Betalin Therapeutics’s Micro Pancreas Ready for Human Trials
Betalin Therapeutics' Micro Pancreas will be tested on humans within 12 months. The biological pancreas contains living islet cells that ...
Read More
Read More
Future Meat Technologies raises $14m in Seed Funding
Israeli start-up Future Meat Technologies has secured $14 million in a seed funding round as it intends to build the ...
Read More
Read More
Carolina Partners Expands Treatment Offerings to Include Revolutionary Brainsway Therapy for OCD
Carolina Partners, one of the most prominent mental and behavioral practices in the country, announced plans to offer patients access ...
Read More
Read More
European Investment Bank VP Attends Signature Event at BiondVax Extending Financing to €24million
The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President ...
Read More
Read More
Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today provided a ...
Read More
Read More
New York Arcview Investor Forum Honors “Father of Cannabis Research” Raphael Mechoulam with $10K Award
The Arcview Group will honor “The Father of Cannabis Research" with a Lifetime Achievement Award and a $10,000 research grant ...
Read More
Read More
RAFA and Panaxia’s Medical Cannabis Oil examined by Israeli Ministry of Health
For the first time in Israeli history, The Israeli Ministry of Health will discuss including medical cannabis in the Health and Drug Baskets ...
Read More
Read More
RenalSense Receives new Innovation Authority $828,000 R&D Grant
The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in ...
Read More
Read More
RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer
RespiDx has created a new spin-off, OmnySense, to commercialize its Multimometer for comprehensive remote checkups. RespiDx has developed a technology ...
Read More
Read More
FameWave Acquisition Marks Kitov’s Transition Into Oncology
Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly ...
Read More
Read More
China’s Regulatory Authority [NMPA] Approves Oramed’s Oral Insulin Capsules IND Application
The Chinese partner of Oramed Pharmaceuticals Inc., Hefei Tianhui Incubator of Technologies Co., Ltd, has reached the significant regulatory milestone of approval of ...
Read More
Read More
Yarok Microbio combines Chemicals with AI to identify Dangerous Bacteria in Produce
Israeli startup Yarok Microbio says it has developed a way to identify life-threatening bacteria in as little as under an hour, before ...
Read More
Read More
Insulin Replacement Company Betalin Therapeutics Raises $2.5m
Israeli diabetes treatment developer Betalin Therapeutics has raised $2.5 million from leading venture capital funds and private investors for its revolutionary treatment, ...
Read More
Read More
Intec Pharma’s Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed 3x Daily Report Positive Results
Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec")presented the preliminary results from a pharmacokinetic (PK) study comparing the Company's Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) ...
Read More
Read More
Clinical Research on Medical Cannabis Inhalers by Rafa & Panaxia Pharmaceutical Industries to offer immediate Pain Relief to Cancer Patients
As a means of providing immediate pain relief for cancer patients, scientists are carrying out clinical research with Rafa and Panaxia, two ...
Read More
Read More
Hadasit, IBM set up digital health accelerator at Hadassah Ein Kerem, first startups already running
Hadasit, the Hadassah Medical Organization’s technology transfer company, has launched Israel’s first biotechnology hub within a medical center. Hadassah Accelerator ...
Read More
Read More
BIONDVAX Edges Closer to Elusive Universal Flu Vaccine
Jerusalem-based BiondVax Pharmaceuticals is edging closer to an unprecedented universal, multi-season and multi-strain flu vaccine capable of protecting all of ...
Read More
Read More
Cancer Treatment Company HIL to Set Up $5 Million Jerusalem Manufacture Center
Jerusalem-based cancer treatment company HIL Applied Medical Ltd. has signed an agreement to lease a 700 square-meter space from The ...
Read More
Read More
Copaxone Rival Mapi Pharma to Build Jerusalem Plant
Israeli drug discovery company Mapi Pharma, which has developed a delayed release version of Copaxone, Teva Pharmaceutical Industries Ltd. drug for ...
Read More
Read More
Video Clips from JLM-BioCity Event: Women Leaders in Bio
Video Clips from the JLM-BioCity Event: "Women Leaders in Bio: Fixing the Gender Imbalance in Healthcare Leadership” Held at Azrieli ...
Read More
Read More
BrainsWay has new Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder
BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment of brain disorders, announced the initiation of “Launchpad ...
Read More
Read More
Blind reads Text, Recognizes Faces using Orcam’s MyEye on US TV program, “Doctors”
Fitzville Martin, AKA Fitz, blind since birth, appeared on US TV program, The Doctors to demonstrate the world’s most advanced ...
Read More
Read More
Future Meat Technologies raises $ 2.2 million for Lab grown Meat
Israeli biotech company, Future Meat Technologies, which develops lab-grown meat, raised $2.2 million last summer in a seed round led by ...
Read More
Read More
Jerusalem-based Air Doctor on Spanish 8madrid TV during their peak hour!
Air Doctor , a Jerusalem-based eHealth startup, provides a marketplace designed to match patients with specialized physicians while traveling. The Company’s platform helps ...
Read More
Read More
Lumir Lab, a Cannabis lab, set up at Hadassit on Hebrew U’s Ein Kerem campus
Israeli holding company Asana Bio Group, now taking its first steps towards growing cannabis in Malta, has invested $2.3 million ...
Read More
Read More
BiondVax’s Universal Flu Vaccine Featured on CNN
BiondVax's Universal Flu Vaccine was recently featured on CNN. They reported the following: Instead of relying on people to get ...
Read More
Read More
Novel Non-Invasive, Painless Low-Level Electromagnetic Radiation Device Targets Early Stage Cancer Tumors
SynergyMed Ltd, is a Jerusalem based medical device startup company that is focusing on the treatment of breast, head & ...
Read More
Read More
Novotalk won the first place at the RESI 2019 Innovation Challenge
In this year's highly competitive RESI (Redefining Early Stage Investments) Innovation Challenge, Novotalk was chosen in first place against many other ...
Read More
Read More
Diagnoz.me won the EHealth 2018!
Home diagnosis kit Jerusalem startup Diagnoz.me has a smartphone system that can detect infections from home and send results to your doctor. Founder ...
Read More
Read More
STEM CELL MEDICINE LICENSES EXOSOME TECHNOLOGY FOR TREATING AUTISM FROM RAMOT, TEL AVIV U
Stem Cell Medicine Ltd. (SCM), a Jerusalem-based biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and ...
Read More
Read More
Scade Medical handheld Skin Cancer Diagnotics Scanner is raising funding for Clinical Trials
Scade Medical, (http://scademedical.com) was founded in 2013 by Dr. Ofir Aharon and Mr. Gabi Mizrahi along with first two investors ...
Read More
Read More
FDA Approves Teva’s First and Only Digital Inhaler with Built-In Sensors
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Read More
Read More
Point of Care Blood Test Co. Sight Diagnostics raises $28m on Start of Marketing of Malaria to Developing Countries
Sight Diagnostics (SightDX), a portfolio company of Anatomy, Clal Biotechnology's investment fund for medical devices, had raised $28 million. When ...
Read More
Read More
Powermat Wireless Charging Founder Ran Poliakine Launches Innovation Center to Advance Early Stage Wearable Technologies
Ran Poliakine, founder and former CEO of Powermat, has established a new Innovation Center designed to foster and develop new and ...
Read More
Read More
RenalSense Conducts Pilot Study on ICU Patient Monitoring at U of Pittsburgh Medical Center
RenalSense® is conducting a pilot study with its Clarity RMS® critical care monitoring system at the University of Pittsburgh Medical Center (UPMC), ...
Read More
Read More
BrainsWay Selected for USA FDA Innovation Challenge to tackle Opioid Addiction
BrainsWay's deep transcranial magnetic stimulation (Deep TMS) system was one of only eight medical devices selected by the U.S. Food ...
Read More
Read More
Pepticom’s AI Discovered 53 Novel Immune-Mmodulators
Pepticom was honored with an image from their article on this December's Journal of Immunology. The image is taken from Pepticom's ...
Read More
Read More
Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game!
While current immunotherapies offer promise to previously untreatable cancers, they only work in a small percentage of patients with certain ...
Read More
Read More
Enlivex Therapeutics merged into NASDAQ-based Co-Bioblast Pharma Ltd, of Dahlia Meggido
Bioblast Pharma Ltd. (Nasdaq:ORPN) announced the execution of a definitive agreement to acquire Enlivex Therapeutics Ltd., a VC-funded privately-held immunotherapy ...
Read More
Read More
Hadasit & IBM set up digital health accelerator at Hadassah Ein Kerem, Jerusalem
Hadassah Medical Center in Jerusalem and IBM Israel have announced the establishment of a special accelerator for startups in which ...
Read More
Read More
Intec Pharma Reports Third Quarter 2018 Financial Results and Corporate Update
Completed enrollment in pivotal Phase 3 ACCORDANCE trial is on track for topline data in mid-2019 JERUSALEM, Nov. 9, 2018 /PRNewswire/ -- Intec Pharma ...
Read More
Read More
Positive results in Entera Bio’s pharmacokinetic (PK) & pharmacodynamic (PD) study in patients with hypoparathyroidism
Entera Bio Ltd. (Nasdaq: ENTX) announced today that it has received positive results from the first part of its pharmacokinetic (PK) ...
Read More
Read More
The New Scientist Reports on Biondvax’s Universal Flu Vaccine
For decades, scientists have been trying to develop a universal vaccine that would protect people against seasonal flu for years, ...
Read More
Read More
Anchiano Therapeutics files for $30-40m Nasdaq offering
Jerusalem based cancer treatment company Anchiano Therapeutics (TASE: ANCN), formerly BioCancell Therapeutics, has announced the publication of a confidential prospectus for an ...
Read More
Read More
Results of Zion Medical’s First Human Clinical Trial of HIV drug Gammora Offers Potential Cure
Zion Medical, an Israeli biotech company developing HIV and cancer treatments, has announced the results of the first clinical trial ...
Read More
Read More
Hebrew U Researchers Develop Technology for 3-D Printing of Drugs
Researchers from Jerusalem’s Hebrew University unveiled their novel technology for three-dimensional printing of drug capsules on Wednesday, enabling the customization ...
Read More
Read More
JLM-based Gamida Cell to raise $69m in Nasdaq IPO/adds Robert Blum as new Chairman of the Board
Jerusalem stem cell cancer therapy developer Gamida Cell Ltd. has filed a registration statement on Form F-1 with the US ...
Read More
Read More
CDC sponsored study: Argaman Technologies reduced by 25% hospital acquired infections and by 40% Multi-Drug Resistant Organisms in Wards!
The University of Pennsylvania Medical School Hospital is to announce the results of a study on the impact of Argaman Technologies ...
Read More
Read More
Densys3D Announces US Dental Depot as Regional US Distributor
Densys3d has entered into a strategic agreement with US Dental Depot as a regional distributor for their intraoral scanner, MIA3D ...
Read More
Read More
Hadassah Hebrew U BioDesign Project, CardioVia, Raises NIS 3 Million & Was Accepted to the NGT3 VC Incubator
Following the June 2018 presentation of bio-med projects in the framework of the BioDesign, a joint program of Hadassah Medical ...
Read More
Read More
NovellusDx Inks Japan Distribution Deal for Cancer Treatment Response Assay
NovellusDx said today that it has signed a deal with Primetech to distribute its u Functional Annotation for Cancer Treatment (FACT) ...
Read More
Read More
Sight Diagnostics Offers an AI-based Diagnostics Device for Faster Blood Tests
Sight Diagnostics, an Israeli medical devices startup in Jerusalem that’s using computer vision and machine learning technology to speed up ...
Read More
Read More
Behavioral Health Care Management Startup Valera Health adds Eau Claire Group Health Cooperative to Customer Base
Valera Health, a behavioral healthcare management startup that developed an app to help clinicians remotely monitor patients with anxiety and ...
Read More
Read More
NovaSight diagnoses and treats Lazy Eye and Concentration Problems by Monitoring Eye Movement
NovaSight system diagnoses eye problems in children and makes it possible to train the eyes in cases of amblyopia (lazy eye) ...
Read More
Read More
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder
This clearance marks the second indication granted for BrainsWay Deep TMS. The first clearance was for treatment of Major Depressive ...
Read More
Read More
US Patent Office Grants NOVELLUSDX Patent for Methods & Systems for identifying Patient-Specific Driver Mutations
NovellusDx, the leader in functional genomics, was granted from the US Patenet Office a new patent titled “METHODS AND SYSTEMS ...
Read More
Read More
BiondVax receives second €6M tranche disbursement from the European Investment Bank (EIB)
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of M‑001, a clinical phase 3 Universal Influenza Vaccine candidate, recently announced the receipt ...
Read More
Read More
MonitHer ‘s New Home-Use Breast Cancer Detection Device Wins WeWork’s $360 K Creator Award
While Yehudit Abrams was working as a postdoctoral fellow at NASA, her job was to research the potential use of ...
Read More
Read More
Analytics Insights Selected BrainQ as One of the 10 Most Innovative Artificial Intelligence Solution Providers for 2018
Analytics Insight announced in their June digital magazine of that BrainQ is one of the most Innovative AI solution providers ...
Read More
Read More
Lab-Made Meat Startup SuperMeat raises $3M Seed to develop ‘Clean’ Chicken
SuperMeat, an Israeli biotech and food-tech startup that is developing lab-made chicken meat, raised early this year $3 million in ...
Read More
Read More
Cellect Signs Strategic Agreement with Swiss Biotech Center (SBC) & with Dresden University denovoMATRIX Team
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a ...
Read More
Read More
Oramed to be Added to Russell Microcap® Index
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Read More
Read More
Prince William exeriences Orcam’s Life Changing Device for Blind People
Prince William, the Duke of Cambridge, has made a truly historic first official visit of a member of the Royal ...
Read More
Read More
Mazor Robotics’ Renaissance System installed at Georgia ASC and at Advocate Lutheran General Hospital in Illinois
In June 2018, GNS Surgery Center, an affiliate of United Surgical Partners International, announced that it has completed their first ...
Read More
Read More
Jerusalem based Entera Bio Ltd. Announces Pricing of IPO for conducting Clinical Trials of Three Orally delivered Drugs targeting the Gastrointestinal Tract
Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule ...
Read More
Read More
Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical ...
Read More
Read More
HIL Co-Founder and CTO, Prof. Arie Zigler, is a finalist for Berthold Leibinger Innovationspreis 2018
June, 2018 - Prof. Arie Zigler, HIL’s Co-Founder and CTO, and a faculty member of the Hebrew University's Physics Department, ...
Read More
Read More
Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors
Positive Results Support Development Pathway of AL101 as a Targeted Therapy for Patients with Tumors That Have Activating Notch Mutations ...
Read More
Read More
Hebrew University Researchers to Collaborate With GRAIL on Methylation Data from Multiple Cell Types to understand How to interpret the Source of blood-based Signals
Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, announced a strategic collaboration with GRAIL, Inc., a healthcare company ...
Read More
Read More
Oramed Initiates a Food Effect Study for its Oral Insulin Capsule ORMD-0801
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced ...
Read More
Read More
Brainsway and Cohen Veterans Bioscience Collaborating in Biomarker Research for Post Traumatic Stress Disorder
Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) Brainsway Ltd.(BRIN.TA), a leader ...
Read More
Read More
InnovationQuarter (NL) visits the Hebrew University BioGiv “Excubator” Infrastructure Center
June 7, 2018 - InnovationQuarter (NL) visited the @BioGiv “Excubator” Infrastructure Center of the Hebrew University at the Hitech Village on ...
Read More
Read More
VideoTherapy to present at the Summer Expo June 28, Cleveland, Ohio
In Spring 2018, Plug and Play Cleveland Innovation Platform began it's first inaugural Health & Wellness accelerator program. Plug and Play evaluated ...
Read More
Read More
Thomas Jefferson University announces Global Center in Jerusalem
June 6, 2018 - Thomas Jefferson University announced Tuesday, June 6 2018, the opening of the Jefferson Israel Center in Jerusalem ...
Read More
Read More
Jerusalem based 6Degrees “Computer Mouse for Amputees”
May 28, 2018 - 6Degrees is developing a unique algorithm that will be embedded within a line of products; the ...
Read More
Read More
Jerusalem-based Kitov Announces Commercialization Agreement for their Drug against Osteoarthritis Pain Consensi™ with China
June 3, 2018 - Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the Company has ...
Read More
Read More
Jerusalem-based Omnix Medical is developing Novel Antibiotic Agents Against Resistant Pathogenic Bacterial Strains
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix ...
Read More
Read More
Jerusalem-based startup Raziel Therapeutics developed an injectable molecule that melts away fat cells
The key to fighting obesity is through diet and lifestyle, experts agree. But a new “fat-melting” injection developed by an ...
Read More
Read More
Atox Bio Announces Enrollment of First Patient in Acute Kidney Injury (AKI) Phase 2 Study
May 30, 2018 - Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, announced that the ...
Read More
Read More
BiondVax is carrying clinical trials out on their universal flu vaccine candidate M-001 in both the US and Europe
May 14 - BioWorld reported that BiondVax puts pegs in place for final push in universal flu vaccine effort http://www.bioworld.com/content/biondvax-puts-pegs-place-final-push-universal-flu-vaccine-effort . Clinical trials ...
Read More
Read More
BrainQ raises $5.3M to treat neurological disorders with the help of AI
May 15, 2018 - BrainQ, a Jerusalem-based digital therapeutics startup that aims to help stroke victims and those with spinal cord injuries ...
Read More
Read More
FDA Clearance Granted to BrainsWay for Next Generation Stimulator
May 7, 2018 - BrainsWay will now have the most advanced stimulator on the market, with enhanced features that increase the ...
Read More
Read More
Tyson leads $2.2m investment in JLM based Future Meat Technologies
May 2, 2018 - Jerusalem-based biotechnology company Future Meat Technologies has received $2.2 million in a seed investment funding round led ...
Read More
Read More
NovellusDx Completes $6M Equity Financing
April 30, 2018 - NovellusDx, a Jerusalem, Israel-based functional genomics company, completed a $6m equity financing. Backers in the round, ...
Read More
Read More
VRHealth selected for Excellence in Healthcare Future Tech Award at 2018 Las Vegas Smart Health Conference
April 27, 2018 - The Smart Health Conference in Las Vegas has selected VRHealth, the Israel-based, virtual reality for physical therapy technology ...
Read More
Read More
Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent
January 11, 2018 - Cordis, a Cardinal Health company, and Medinol announced that the first commercial cases using the EluNIR™ drug-eluting ...
Read More
Read More
Group Health Cooperative Eau Claire Partners with Valera Health in Innovative Behavioral Health Management
January 18, 2018 Brooklyn-based behavioural health startup Valera Health and Group Health Cooperative of Eau Claire have announced a partnership ...
Read More
Read More
Oramed’s Nadav Kidron Interviewed on Las Vegas TV about their Oral Insulin Capsule
March 19, 2018 Nadav Kidron, CEO of Oramed Pharmaceuticals Inc. was recently interviewed by KTNV Channel 13 Action News on ...
Read More
Read More
Brainsway to open 8 new TMS centers with the Trinitas-St. Joseph’s Behavioral Health Network
April 4, 2017 - Brainsway will be opening 8 new TMS centers with the Trinitas-St. Joseph’s Behavioral Health Network. Trinitas-St ...
Read More
Read More
The Israeli Ministry of Health Grants Hadassah/Hadasit Laboratory Facilities GMP Compliance Status
Feb 28, 2018 - In December 2017, Israel’s Ministry of Health granted Hadassah’s Good Manufacturing Practice (GMP) biological production facility certification for ...
Read More
Read More
Hadasit Signs New Research Collaboration Agreement with Genentech
February 28, 2018 - Hadasit has signed a research collaboration agreement with Genentech, a member of the Roche Group, with ...
Read More
Read More
Bio-Giv opened its New Facilities at Hebrew University’s Hitech Village on the Givat Ram Campus – Already 7 Companies Signed up!
March 14, 2018 - A small informal ceremony took place today marking the fixing of the Mezuzahs at the new ...
Read More
Read More
JLM-based Tissue Dynamics validated its groundbreaking technology with some of the world’s largest Cosmetic and Pharmaceutical companies!!
March 20, 2018 - Tissue Dynamics Ltd. validated its groundbreaking technology with some of the largest Cosmetic and Pharmaceutical companies worldwide ...
Read More
Read More
Betalin Therapeutics won second prize at the Chinese IPIEC Global 2017 competition receiving $100K award
Xi'an International Entrepreneurship Competition (abbreviated as “XIEC”) is a Chinese annual international innovation and entrepreneurship conference for cooperation and communication through ...
Read More
Read More
Israeli Ministry of Foreign Affairs diplomatic corps cadets get a taste of the Jerusalem Bio and Life Science Innovation scene
March5, 2018 – The Israeli Ministry of Foreign Affairs cadets were given an overview of the Jerusalem Bio and Life Science Innovation ...
Read More
Read More
Teva Plant in JLM is the Right Facility to become a CDMO, this is a win-win situation for Teva and Contract Manufacturers to save an excellent crew with an excellent site.
Teva is downsizing and shedding some of its manufacturing facilities here in Israel, including two of its manufacturing facilities in ...
Read More
Read More
Jlm-Based Orcam Raised $ 30.4 Million at a Value of $ 1 Billion
February 20, 2018 - $1.01B: Jerusalem -based computer vision startup OrCam Technologies, which has developed a visual aid for the blind, became ...
Read More
Read More
Alynnovation is Open for Entrepreneurs in Assistive Technologies for Children
March 7, 2018 ALYN Hospital has opened ALYNnovation, a commercial track that partners with entrepreneurs and inventors in developing and commercializing assistive technology products and solutions for ...
Read More
Read More
Granalix’s Pomegranate Extract is an Israeli Supplement for Preventing and Improving Neurodegenerative Diseases
February 26, 2018 - Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, ...
Read More
Read More
Ran Poliakine’s New Innovation Center is Now Open for Applications
Feb 8, 2018 - Ran Poliakine of Nveh Ilan hase just announced the launch of a brand-new innovation center that intends to ...
Read More
Read More
Prof. David Naor’s Drug Could Treat Alzheimer’s, MS, Crohn’s and More
February 11,2018 Prof. David Naor, from the Lautenberg Center for General and Tumor Immunology at the Hebrew University-Hadassah Medical School, Jerusalem, believes ...
Read More
Read More
BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer
Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioCancell Therapeutics (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ...
Read More
Read More
Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH With its Oral Insulin Capsule
Nov. 14, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of ...
Read More
Read More
World first MRI for the NeoNatal ICU has been successfully working at Jerusalem’s Shaare Zedek Medical Center for the last three months
January 10, 2018 Aspect Imaging 's Embrace® dedicated Neonatal Magnetic Resonance Imaging (MRI) system has now received both the EC ...
Read More
Read More
First patients Enrolled in Immuron’s IMM-529 Clinical Study at Hadassah Medical Center in Israel
January 31, 2018 - Immuron (ASX:IMC) (NASDQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing oral immune-therapeutics for the ...
Read More
Read More
Shaare Zedek Medical Center Signs MoU with Indian Central Council for Research in Homeopathy
January 18, 2018 The Centre for Integrative Complementary Medicine of Shaare Zedek Medical Center in Jerusalem signed a pact with the Central Council for Research ...
Read More
Read More
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as CMO
January 31, 2018 - Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based ...
Read More
Read More
The MUSE(TM) Procedure for GERD Treatment Performed First Time in Israel at Shaare-Zedek Medical Center
Dec 27, 2017 - Dr. Wengrower, Head, Therapeutic Endoscopy Unit, and his colleagues Dr. Paz and Dr. Livovsky at the ...
Read More
Read More
First Annual OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit, was given this year to Dr. Morry Blumenfeld
Feb 1, 2018 Dr. Morry Blumenfeld, a legend in the field of medical technology development as well as MedTech investment, ...
Read More
Read More
The 2018 OurCrowd Global Investment Summit highlighted Israeli Digital Health Technologies
Feb 5, 2018 OurCrowd, one of the largest investment crowdfunding platforms in the world, held their annual summit at the International ...
Read More
Read More
Opportunities for Israeli Companies in Mexico and California
Here are the Highlights of the Cali-Israel-Mexico Innovation Expo Recruitment Presentation January 24th, 2018, Jerusalem Israel. JLM-BioCity, JBNF, Regus Co-Working ...
Read More
Read More
JLM based Entera Bio sets terms for $60m Nasdaq IPO
DNA Biomedical Solutions Ltd. (TASE: DNA) subsidiary Entera Bio has set the terms for a Nasdaq IPO to raise $50 million - $60 ...
Read More
Read More
Oramed Pharma’s CEO Issues Letter to Shareholders
Jan 19, 2017 Dear Shareholders, All the hard work and dedication in 2017 has successfully positioned Oramed to initiate a ...
Read More
Read More
OrCam Launched Next Generation of Artificial Vision for the Visually Impaired
Janaury 7, 2017 OrCam displayed their artificial vision technology, OrCam MyEye 2.0, at CES 2018. MyEye was been named a CES Innovation Awards honoree and a finalist ...
Read More
Read More
JLM based Salignostics Ltd is carrying out free saliva based pregnancy tests for a limited period of time
Dec 14, 2017 JLM based Salignostics Ltd has developed a novel pregnancy rapid home- test utilizing saliva. This is the ...
Read More
Read More
Kitov Pharmaceuticals Announces Receipt of FDA’s Favorable Response to NT219’s pre-IND Meeting Package
Nov 11, 2017 - NT219 works by overcoming drug resistance of pancreatic cancer to various oncology drugs. Kitov Pharmaceuticals (NASDAQ: KTOV; ...
Read More
Read More
Granalix BioTechnologies, founded by Prof Ruth Gabizon, is marketing a Novel Food Additive Based On Pomegranate Oil For Protection From Neurodegenerative Diseases
Granalix BioTechnologies, following its commercial launch last year of GranaGard™ a food supplement based on pomegranate oil that was shown to prevent ...
Read More
Read More
Updated Version of Oncological Drugs Rating Tool, developed by Prof. Nathan Cherny from Shaare Zedek Medical Center
Novermber 10, 2017 The new version of an international oncological drugs rating tool, developed by Prof. Nathan Cherny from Shaare ...
Read More
Read More
JLM based Neteera Expands Market Reach and Senior Management
Dec 12, 2017: Neteera Technologies Ltd. [http://www.neteera.com ] announced the addition of Jason Rudd and Ilya Vatsel to the company's senior ...
Read More
Read More
Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round
JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCancell Therapeutics (TASE:BICL), http://www.biocancell.com/ a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Read More
Read More
Gamida Cell reports positive cancer drug trial
The company is preparing for an IPO next year, after recently raising money at a $160 million company value. Dec ...
Read More
Read More
Brainsway raises $8.5m amid record revenue growth
Dec 11, 2017 - The company awaits a response from the FDA to an application to approve its product for use ...
Read More
Read More
Gamida Cell Presents New Data from Key Programs at 2017 ASH Annual Meeting
Nov 1, 2017 - Gamida Cell, a leading cellular and immune therapeutics company based in Jerusalem, announced that two oral presentations ...
Read More
Read More
JLM-based Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial
Oct 11, 2017 - Izun Pharmaceuticals Corporation (“Izun”, “Company”, izunpharma.com), a clinical stage company focused on developing high efficacy products ...
Read More
Read More
Chemo Group Invests in Modiin Based OCON Medical
Oct 17, 2017 - Ocon Medical has developed the IUB, a proprietary intrauterine platform made of a super-elastic alloy. Global healthcare ...
Read More
Read More
NovellusDx Elected to Pitch at the Galien Annual Event in New York this week
Oct 23, 2017 - NovellusDx has been selected again by the Galien Foundation organizing committee to pitch and participate in The Galien ...
Read More
Read More
CIITECH Sponsors Research Project on Cannabis-Based Therapy for Asthma at Hebrew U’s Center on Cannabinoid Research
Oct 24, 2017 - CIITECH, a UK-Israel cannabis biotech startup, announced today that it has selected to sponsor a research project with ...
Read More
Read More
STK & Liddor Paving the way for New Biological Pipeline Production in Beit Shemesh
Oct 24 - 2017 - STK (Stockton), a leading company in the development and marketing of botanical based solutions for food ...
Read More
Read More
Abigail Leichman, Israel21C, Reports on 10 of the Coolest Biotech Companies in Jerusalem
September 25, 2017 - Amazing new technologies for beating conditions including breast cancer, ALS and obesity are under development in Israel’s ...
Read More
Read More
$ 25 million investment to VC fund, Integra Holdings, who is bringing the Hebrew U’s Life Science Academic Excellence to market, led by Temasek (SIngapore)
September 27th, 2017 – Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, ...
Read More
Read More
Korea Investment Partners to finance Jlm-based Enlivex Therapeutics’s lead compound for the prevention of Graft Vs Host Disease (GVHD)
Sept 20, 2017 - Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, announced today the closing of an $8 million equity financing round ...
Read More
Read More
Rosetrees Trust Interdisciplinary Prize awarded to Hebrew U scientists Yaakov Nahmias and Nir Friedman
Sept 18, 2017 - The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University ...
Read More
Read More
JLM-based BreathVision’s Breath Volume Monitoring keeps Patients Safe in the Operating Room
Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with ...
Read More
Read More
Medtronic to open development centers in Jerusalem & Yokneam in cooperation with the Israel Innovation Authority
Sept 11, 2017 - Medical equipment company Medtronic will be the first company to establish development centers in Israel in ...
Read More
Read More
Iowa Economic Mission Meets Jerusalem Biotech Leaders
Jerusalem, Israel - Sept. 11, 2017 - The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met ...
Read More
Read More
JLM based Entera Bio Raising $10m at $94m Valuation
Sept 13, 2017 - Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for ...
Read More
Read More
BiondVax to Manufacture its Universal Flu Vaccine in Jerusalem!
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu ...
Read More
Read More
CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration
If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to ...
Read More
Read More
Brainsway’s Backlog Revenues Due to Future Lease Agreements Increased 27% to $19 Million
Aug 22 2017 - Jerusalem based Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced ...
Read More
Read More
New drug-testing technology from the Hebrew University could drastically cut animal testing
Aug 22 - Prof Yakov Nahmias's human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and ...
Read More
Read More
Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
August 21, 2017 — The first subject has been transplanted in an investigator-initiated study of Cordin™ for patients with severe ...
Read More
Read More
Automatic Accurate Method for Measuring Blood Pressure Developed by Lev Academic Center (Jerusalem College of Technology)
Aug 12, 2017 - Automatic blood pressure devices are often used to assess blood pressure levels at home and in ...
Read More
Read More
HIL Applied Medical names Reno, Nevada its North American headquarters after University Collaboration
Aug 4, 2017 A continuing collaboration between Jerusalem-based HIL Applied Medical and the University of Nevada, Reno has led to ...
Read More
Read More
Oramed: On To Phase III And The Tel Aviv Stock Exchange
Aug 9 2017 - Oral Insulin Can Change the Diabetes Market Fundamentally and right now the company closest to succeeding in this ...
Read More
Read More
ORAMED appoints Dr. Simon Bruce as Vice President of Medical Affairs
July 18 2017 - ORAMED Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today the appointment of Dr. Simon Bruce MD ...
Read More
Read More
BioTime and CellCure open cGMP cell therapy manufacturing site in Israel
January 3, 2017 -BioTime and its majority-owned subsidiary, CellCure Neurosciences, opened a new, 800-m2 cGMP cell therapy manufacturing facility at the ...
Read More
Read More
Gamida Cell Announces $3.5 Million Grant from the Israeli Government
July 20 2017 - Jerusalem- based Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer ...
Read More
Read More
New partnership between Christiana Care’s Gene Editing Institute and NovellusDx aims to improve personalized cancer medicine
July 20 2017 - Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene ...
Read More
Read More
The Aerodentis braces clinical trial sheds metal brackets
The Aerodentis braces has started new clinical trials at the University of Alabama at Birmingham School of Dentistry. The treatment, called ...
Read More
Read More
Aeon Pharmaceuticals wins 1st place in the Pitch Competition of the Bio Executive Forum
Aeon Pharmaceuticals , a Jerusalem company, is developing a detoxification antidote to treat ER (Emergency Room) patients for alcohol poisoning. Alcohol ...
Read More
Read More
BioFeed launched novel solutions for pest-control during PM’s Modi and Netanyahu visit
July 6 2017 - Biofeed launched a novel solution to the Bactrocera dorsalis and Bactrocera zonata fruit flies during a visit ...
Read More
Read More
Congratulations to Anan Copty, Butros Hallac, and NIMD on getting awarded a CIIRDF grant
NIMD, Non Invasive Medical Devices, a Jerusalem-based medical device startup company focused on the treatment of cancer, has been awarded ...
Read More
Read More
Gamida Cell Ltd closes today $40 million financing!
Jerusalem based Gamida Cell Ltd., a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, ...
Read More
Read More
Brainsway’s deep-TMS study in Obsessive Compulsive Disorder (OCD) Patients produces positive final results
Brainsway, located in Jerusalem, is preparing a submission to the FDA to market the device for Obsessive Compulsive Disorder (OCD) . Its ...
Read More
Read More
Betalin Therapeutics is working to cure diabetes by making Micro-Pancreases
Betalin Therapeutics is developing an Engineered Micro Pancreas (EMP) to improve the quality of life for millions of people with ...
Read More
Read More
6Degrees is looking for pilot trial candidates to try out their new device controls digital devices for people who have lost their hand dexterity
6Degrees has developed a smart band that allows people who have lost their hand dexterity full control of digital smart ...
Read More
Read More
JLM based Entera Bio files for Nasdaq IPO
Entera Bio, a portfolio company of DNA Biomedical Solutions Ltd. (TASE: DNA) located in Jerusalem, has announced the filing of ...
Read More
Read More
Jerusalem based Oramed to dual list on TASE
Jerusalem based Oramed Pharmaceuticals Inc. (Nasdaq:ORMP), which develops orally administered drugs as a substitute for injections, has announced that the Israel ...
Read More
Read More
FDA approves Curasite™ Hydrogel Wound Care Product by JLM based Izun Pharmaceuticals
The FDA has approved the Izun Pharmaceuticals’ 510(k) application for Curasite™ Wound Care Hydrogel. Curasite™ is a proprietary topical combination ...
Read More
Read More
JLM based Novolaka from AtoBe won first place at the Global Pitch in China
Novalaka won first place from the 120 medical start-ups that presented. NovaLaka is an innovator of slow release drug delivery ...
Read More
Read More
Fortissimo buys Beit Shemesh Medical Equipment Company Tuttnauer for $100m
Fortissimo Capital has signed an agreement to acquire 100% ownership of Tuttnauer medical sterilization equipment company for $100 million. Fortissim is ...
Read More
Read More
Innovation Center for Special-Needs Kids opens at Jerusalem’s Alyn Pediatric Rehab Hospital
The Alyn Pediatric Rehab Hospital’s new facility, Innovation Center for Special-Needs Kids, will accelerate the invention of case-specific, as well ...
Read More
Read More
Herzog Hospital opened the new Samson building on May 16, 2017 and moved two departments
Founded in 1894, Herzog Hospital located at in the entrance to the city of Jerusalem, aims at improving the quality of life ...
Read More
Read More
Shaare Zedek Medical Center is offering services to medical, bio companies and researchers
Medical device and biotechnological companies, researchers and CROs… Looking for advanced medical equipment and facilities? A professional site at which ...
Read More
Read More
Hebrew University’s New Brain Research Center
This week, the Hebrew University of Jerusalem is dedicating its new interdisciplinary center for brain sciences. The Edmond and Lily Safra ...
Read More
Read More
